Cancer tissue engineering: A novel 3D polystyrene scaffold for in vitro isolation and amplification of lymphoma cancer cells from heterogeneous Cell mixtures

Journal of Tissue Engineering

Volumn 2, Issue 1, 2011, Pages 1-10

  Caicedo Carvajal, Carlos E ^a   Liu, Qing ^a   Remache, Yvonne ^b   Goy, Andre ^b   Suh, K Stephen ^b  

^a 3D Biotek LLC   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENGINEERING; CELL PROLIFERATION; DISEASES; POLYSTYRENES; SCAFFOLDS (BIOLOGY); SELF ASSEMBLY; TISSUE; TISSUE CULTURE;

3-DIMENSION; CANCER CELLS; CANCER TISSUES; CELL MIXTURES; CO-CULTURES; CULTURE ENVIRONMENTS; IN-VITRO; IN-VIVO; LYMPHOMA CELLS; TISSUES ENGINEERINGS;

ONCOLOGY;

EID: 84890242991     PISSN: None     EISSN: 20417314     Source Type: Journal    
DOI: 10.4061/2011/362326     Document Type: Article

References (48)

1. A. Nyga, U. Cheema, and M. Loizidou, "3D tumour models: novel in vitro approaches to cancer studies," Journal of Cell Communication and Signaling, vol. 5, no. 4, pp. 239-248, 1924.
2. S. Krause, M. V. Maffini, A. M. Soto, and C. Sonnenschein, "The microenvironment determines the breast cancer cells' phenotype: organization of MCF7 cells in 3D cultures," BMC Cancer, vol. 10, article no. 263, 2010.
3. C. J. Olsen, J. Moreira, E. M. Lukanidin, and N. S. Ambartsumian, "Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts," BMC Cancer, p. 444, 2010.
4. A. Starzec, D. Briane, M. Kraemer et al., "Spatial organization of three-dimensional cocultures of adriamycin-sensitive and - resistant human breast cancer MCF-7 cells," Biology of the Cell, vol. 95, no. 5, pp. 257-264, 2003.
5. M. Leung, F. M. Kievit, S. J. Florczyk et al., "Chitosan-alginate scaffold culture system for hepatocellular carcinoma increases malignancy and drug resistance," Pharmaceutical Research, vol. 27, no. 9, pp. 1939-1948, 2010.
6. M. P. V. Shekhar, "Drug resistance: challenges to effective therapy," Current Cancer Drug Targets, vol. 11, no. 5, pp. 613-623, 2011.
7. C. Fischbach, R. Chen, T. Matsumoto et al., "Engineering tumors with 3D scaffolds," Nature Methods, vol. 4, no. 10, pp. 855-860, 2007.
8. K. Mi, G. Wang, Z. Liu, Z. Feng, B. Huang, and X. Zhao, "Influence of a self-assembling peptide, RADA16, compared with collagen I and matrigel on the malignant phenotype of human breast-cancer cells in 3D cultures and in vivo," Macromolecular Bioscience, vol. 9, no. 5, pp. 437-443, 2009.
9. L. A. Gurski, A. K. Jha, C. Zhang, X. Jia, and M. C. Farach- Carson, "Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells," Biomaterials, vol. 30, no. 30, pp. 6076-6085, 2009.
10. G. Benton, H. K. Kleinman, J. George, and I. Arnaoutova, "Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells," International Journal of Cancer, vol. 128, no. 8, pp. 1751-1757, 2011.
11. E. Burdett, F. K. Kasper, A. G. Mikos, and J. A. Ludwig, "Engineering tumors: a tissue engineering perspective in cancer biology," Tissue Engineering Part B, vol. 16, no. 3, pp. 351-359, 2010.
12. J. L. Horning, S. K. Sahoo, S. Vijayaraghavalu et al., "3-D tumor model for in vitro evaluation of anticancer drugs," Molecular Pharmaceutics, vol. 5, no. 5, pp. 849-862, 2008.
13. H. K. Dhiman, A. R. Ray, and A. K. Panda, "Threedimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen," Biomaterials, vol. 26, no. 9, pp. 979-986, 2005.
14. S. S. Verbridge, E. M. Chandler, and C. Fischbach, "Tissueengineered three-dimensional tumor models to study tumor angiogenesis," Tissue Engineering Part A, vol. 16, no. 7, pp. 2147-2152, 2010.
15. M. K. Bergenstock et al., "Engineered polystirene scaffolds for in vitro three-dimensional diesease models," in Proceedings of the Trans of the 34th Society for Biomaterials, Seatle, Wash, USA, 2010.
16. J. A. Tuxhorn, G. E. Ayala, and D. R. Rowley, "Reactive stroma in prostate cancer progression," Journal of Urology, vol. 166, no. 6, pp. 2472-2483, 2001.
17. J. W. Franses, A. B. Baker, V. C. Chitalia, and E. R. Edelman, "Stromal endothelial cells directly influence cancer progression," Science Translational Medicine, vol. 3, no. 66, article 66ra5, 2011.
18. B. S. Wiseman and Z. Werb, "Development: stromal effects on mammary gland development and breast cancer," Science, vol. 296, no. 5570, pp. 1046-1049, 2002.
19. K. Rasanen and A. Vaheri, "Activation of fibroblasts in cancer stroma," Experimental Cell Research, vol. 316, no. 17, pp. 2713-2722, 2010.
20. E. J. McCave, C. A. P. Cass, K. J. L. Burg, and B. W. Booth, "The normal microenvironment directs mammary gland development," Journal of Mammary Gland Biology and Neoplasia, vol. 15, no. 3, pp. 291-299, 2010.
21. L. Kass, J. T. Erler, M. Dembo, and V. M. Weaver, "Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis," International Journal of Biochemistry and Cell Biology, vol. 39, no. 11, pp. 1987-1994, 2007.
22. Y. C. Wong, X. H. Wang, and M. T. Ling, "Prostate development and carcinogenesis," International Review of Cytology, vol. 227, pp. 65-130, 2003.
23. N. Di Maggio, E. Piccinini, M. Jaworski, A. Trumpp, D. J. Wendt, and I. Martin, "Toward modeling the bone marrow niche using scaffold-based 3D culture systems," Biomaterials, vol. 32, no. 2, pp. 321-329, 2011.
24. A. L. Fletcher, D. Malhotra, and S. J. Turley, "Lymph node stroma broaden the peripheral tolerance paradigm," Trends in Immunology, vol. 32, no. 1, pp. 12-18, 2011.
25. P. Martin, M. Coleman, and J. P. Leonard, "Progress in mantlecell lymphoma," Journal of Clinical Oncology, vol. 27, no. 4, pp. 481-483, 2009.
26. S. A. Pileri and B. Falini, "Mantle cell lymphoma," Haematologica, vol. 94, no. 11, pp. 1488-1492, 2009.
27. L. Alinari, V. L. White, C. T. Earl et al., "Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma," MAbs, vol. 1, no. 1, pp. 31-40, 2009.
28. K. S. Suh and A. Goy, "Bortezomib in mantle cell lymphoma," Future Oncology, vol. 4, no. 2, pp. 149-168, 2008.
29. L. Rittié and G. J. Fisher, "Isolation and culture of skin fibroblasts," Methods in Molecular Medicine, vol. 117, pp. 83-98, 2005.
30. B. Herreros, A. Sanchez-Aguilera, and M. A. Piris, "Lymphoma microenvironment: culprit or innocent?" Leukemia, vol. 22, no. 1, pp. 49-58, 2008.
31. A. Goy and T. Feldman, "Expanding therapeutic options in mantle cell lymphoma," Clinical lymphoma & myeloma, vol. 7, pp. S184-S191, 2007.
32. J. Rodriguez, A. Gutierrez, A. Obrador-Hevia, S. Fernandez DeMattos, and F. Cabanillas, "Therapeutic concepts in mantle cell lymphoma," European Journal of Haematology, vol. 85, no. 5, pp. 371-386, 2010.
33. A. V. Kurtova, A. T. Tamayo, R. J. Ford, and J. A. Burger, "Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting," Blood, vol. 113, no. 19, pp. 4604-4613, 2009.
34. G. Døsen-Dahl, E. Munthe, M. K. Nygren, H. Stubberud, M. E. Hystad, and E. Rian, "Bone marrow stroma cells regulate TIEG1 expression in acute lymphoblastic leukemia cells: role of TGFβ/BMP-6 and TIEG1 in chemotherapy escape," International Journal of Cancer, vol. 123, no. 12, pp. 2759-2766, 2008.
35. T. Lwin, L. A. Hazlehurst, Z. Li et al., "Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-κB (RelB/p52) in non-Hodgkin's lymphoma cells," Leukemia, vol. 21, no. 7, pp. 1521-1531, 2007.
36. C. J. Baglole, D. M. Ray, S. H. Bernstein et al., "More than structural cells, fibroblasts create and orchestrate the tumor microenvironment," Immunological Investigations, vol. 35, no. 3-4, pp. 297-325, 2006.
37. N. S. Andersen, J. K. Larsen, J. Christiansen et al., "Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures," Blood, vol. 96, no. 6, pp. 2219-2225, 2000.
38. H. P. J. Visser, M. Tewis, Willemze R, and J. C. Kluin- Nelemans, "Mantle cell lymphoma proliferates upon IL-10 in the CD40 system," Leukemia, vol. 14, no. 8, pp. 1483-1489, 2000.
39. C. A. Tucker, G. Bebb, R. J. Klasa et al., "Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma," Leukemia Research, vol. 30, no. 4, pp. 449-457, 2006.
40. C. L. Da Silva, R. Gonçalves, K. B. Crapnell, J. M. S. Cabral, E. D. Zanjani, and G. Almeida-Porada, "A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells," Experimental Hematology, vol. 33, no. 7, pp. 828-835, 2005.
41. T. Umiel, S. Friedman, and R. Zaizov, "Long-term culture of infant leukemia cells: dependence upon stromal cells from the bone marrow and bilineage differentiation," Leukemia Research, vol. 10, no. 8, pp. 1007-1013, 1986.
42. A. B. J. Prowse, L. R. McQuade, K. J. Bryant, D. D. Van Dyk, B. E. Tuch, and P. P. Gray, "A proteome analysis of conditioned media from human neonatal fibroblasts used in the maintenance of human embryonic stem cells," Proteomics, vol. 5, no. 4, pp. 978-989, 2005.
43. J. G. Toma, I. A. McKenzie, D. Bagli, and F.D. Miller, "Isolation and characterization of multipotent skin-derived precursors from human skin," Stem Cells, vol. 23, no. 6, pp. 727-737, 2005.
44. M. Michelini, V. Franceschini, S. Sihui Chen et al., "Primate embryonic stem cells create their own niche while differentiating in three-dimensional culture systems," Cell Proliferation, vol. 39, no. 3, pp. 217-229, 2006.
45. N. Li, M. Fukunaga-Kalabis, H. Yu et al., "Human dermal stem cells differentiate into functional epidermal melanocytes," Journal of Cell Science, vol. 123, no. 6, pp. 853-860, 2010.
46. C. Dierks, J. Grbic, K. Zirlik et al., "Essential role of stromally induced hedgehog signaling in B-cell malignancies," Nature Medicine, vol. 13, no. 8, pp. 944-951, 2007.
47. J. G. Gribben, "Implications of the tumor microenvironment on survival and disease response in follicular lymphoma," Current Opinion in Oncology, vol. 22, no. 5, pp. 424-430, 2010.
48. J. E. Fortney, W. Zhao, S. L. Wenger, and L. F. Gibson, "Bone marrow stromal cells regulate caspase 3 activity in leukemic cells during chemotherapy," Leukemia Research, vol. 25, no. 10, pp. 901-907, 2001.